Los Angeles Chargers head coach Jim Harbaugh truly lives by "faith, family, football," and he called it "inspiring" to see other NFL stars so open about doing the same.

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright ...

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a ...

Los Angeles Chargers head coach Jim Harbaugh shared his view on the controversial tush push, saying teams either have to "get ...

Yahoo Sports NFL analyst Nate Tice is joined by fantasy analyst Matt Harmon and NFL writer Charles McDonald at the NFL ...

Yahoo Sports’ Caroline Fenton, Jason Fitz, and basketball analyst Isis "Ice" Young explain why the USC star guard is the correct pick for player of the year in women's college basketball this year.

In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Invivyd (IVVD – Research Report), with a price ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

Find insight on Smith & Nephew, Raffles Medical Group and more in the latest Market Talks covering the Health Care sector.

Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent ...

FDA denies Invivyd's EUA expansion for Pemgarda in Covid treatment while BioCryst reports positive Orladeyo data. AN2 changes endpoint, OS Therapies seeks partners & Eyenovia restructures.